Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamdouh M Ali

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|November 6, 2012
Synthesis and docking studies of novel antitumor benzimidazolesMohamed A Omar, Yasser M Shaker, Shadia A Galal, et al.
Carbohydrate Polymers|May 22, 2013
Levansucrase optimization using solid state fermentation and levan biological activities studiesMona A Esawy, Azza M Abdel-Fattah, Mamdouh M Ali, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activityShadia A Galal, Sarah H M Khairat, Fatma A F Ragab, et al.
European Journal of Medicinal Chemistry|February 29, 2016
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivativesWagdy M Eldehna, Sahar M Abou-Seri, Ahmed M El Kerdawy, et al.
European Journal of Medicinal Chemistry|June 15, 2015
Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular dockingWagdy M Eldehna, Mohamed Fares, Hany S Ibrahim, et al.
European Journal of Medicinal Chemistry|May 16, 2017
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitorsMona A Abdullaziz, Heba T Abdel-Mohsen, Ahmed M El Kerdawy, et al.
European Journal of Medicinal Chemistry|September 10, 2013
Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptorShadia A Galal, Ahmed S Abdelsamie, Salwa M Soliman, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|September 13, 2018
Benzimidazole - Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitorAsmaa A Magd-El-Din, Hanan A Mousa, Ammar A Labib, et al.
Molecules (Basel, Switzerland)|February 15, 2020
Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted BenzimidazolesHeba T Abdel-Mohsen, Mona A Abdullaziz, Ahmed M El Kerdawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 9, 2015
Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivativesYasser M Shaker, Mohamed A Omar, Khaled Mahmoud, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|November 6, 2012
Synthesis and docking studies of novel antitumor benzimidazolesMohamed A Omar, Yasser M Shaker, Shadia A Galal, et al.
Carbohydrate Polymers|May 22, 2013
Levansucrase optimization using solid state fermentation and levan biological activities studiesMona A Esawy, Azza M Abdel-Fattah, Mamdouh M Ali, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activityShadia A Galal, Sarah H M Khairat, Fatma A F Ragab, et al.
European Journal of Medicinal Chemistry|February 29, 2016
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivativesWagdy M Eldehna, Sahar M Abou-Seri, Ahmed M El Kerdawy, et al.
European Journal of Medicinal Chemistry|June 15, 2015
Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular dockingWagdy M Eldehna, Mohamed Fares, Hany S Ibrahim, et al.
European Journal of Medicinal Chemistry|May 16, 2017
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitorsMona A Abdullaziz, Heba T Abdel-Mohsen, Ahmed M El Kerdawy, et al.
European Journal of Medicinal Chemistry|September 10, 2013
Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptorShadia A Galal, Ahmed S Abdelsamie, Salwa M Soliman, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|September 13, 2018
Benzimidazole - Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitorAsmaa A Magd-El-Din, Hanan A Mousa, Ammar A Labib, et al.
Molecules (Basel, Switzerland)|February 15, 2020
Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted BenzimidazolesHeba T Abdel-Mohsen, Mona A Abdullaziz, Ahmed M El Kerdawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 9, 2015
Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivativesYasser M Shaker, Mohamed A Omar, Khaled Mahmoud, et al.
Pageof 6